Images List Premium Download Classic

Dysmenorrhea

Dysmenorrhea-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Compound having ep2 agonist activity
August 02, 2018 - N°20180215747

(wherein all symbols are as defined in the description), a salt or n-oxide of the compound, or a solvate or prodrug of the compound or the salt or n-oxide has an ep2 agonist activity and is highly safe, and is therefore useful as a medicine, particularly a therapeutic agent for diseases associated with ep2 receptors, such as immune diseases, allergic ...
Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical ...
Druggability Technologies Ip Holdco Limited
January 04, 2018 - N°20180000845

Disclosed herein are stable complexes with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound celecoxib, its salts, or derivatives thereof, which is useful in the treatment of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute pain especially in cancer related acute pain, primary dysmenorrhea. More specifically, the complexes possess instantaneous redispersibility, increased apparent ...
Trimegestone (tmg) for treatment of preterm birth
Dignity Health
January 04, 2018 - N°20180000838

As disclosed herein, novel compositions including steroid hormones, such as trimegestone (tmg) and progesterone (p4), provide treatments for term and preterm labor with significant effects on the delay of delivery. Delay and block of delivery occurs when both p4 and tmg are administered late in gestation in pregnant rat and guinea pig animal models.
Dysmenorrhea Patent Pack
Download + patent application PDFs
Dysmenorrhea Patent Applications
Download + Dysmenorrhea-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dysmenorrhea-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Systems and methods for managing symptoms associated with dysmenorrhea using an electro-dermal patch
Elira Therapeutics Llc
May 11, 2017 - N°20170128722

A wearable device for treating dysmenorrhea in a patient includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation from the external surface of the patient's epidermal layer through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis by applying electrical stimulation to the epidermis of a t9 ...
Oral formulations of pyrrolidine derivatives
Obseva S.a.
March 09, 2017 - N°20170065556

The present invention relates to solid oral formulations comprising a compound of formula (3z,5s)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one-o-methyloxime, and/or an active metabolite thereof, and the use of said formulations in the treatment and/or prevention of preterm labor, premature birth, dysmenorrhea and embryo implantation failure due to uterine contractions. ...
Vesicular formulations
Sequessome Technology Holdings Limited
February 09, 2017 - N°20170035788

Disclosed herein are vesicular formulations that include one or more phospholipids and one or more surfactants and in certain embodiments the use of such formulations for the delivery of fatty acids for the treatment of disorders such as fatty acid metabolic disorders, including essential fatty acid deficiency; pain or inflammation or osteoarthritis, more specifically for the treatment of deep tissue ...
Dysmenorrhea Patent Pack
Download + patent application PDFs
Dysmenorrhea Patent Applications
Download + Dysmenorrhea-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dysmenorrhea-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation
The Regents Of The University Of California
October 06, 2016 - N°20160289299

The present application generally relates to methods to prevent or treat bleeding and/or hypocoagulation in an individual in need thereof, and compositions for use in such methods. The methods comprise administration of fva, preferably an apc resistant fva (such as superfva), alone or in combination with fviia, preferably rhfviia (such as novoseven® or another fviia having enhanced activity ...
Trimegestone (tmg) for treatment of preterm birth
June 23, 2016 - N°20160175325

As disclosed herein, novel compositions including steroid hormones, such as trimegestone (tmg) and progesterone (p4), provide treatments for term and preterm labor with significant effects on the delay of delivery. Delay and block of delivery occurs when both p4 and tmg are administered late in gestation in pregnant rat and guinea pig animal models.
Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof
Medwell Laboratories Ltd.
May 05, 2016 - N°20160120995

Novel chemical conjugates derived from unsaturated fatty acids and therapeutically active agents, are disclosed. The chemical conjugates are designed and characterized as cox-2 and/or 5-lox inhibitors and are useful in the treatment of inflammatory diseases, dermatitis and disorders such as alzheimer's disease, parkinson's disease, asthma, osteoarthritis, rheumatoid arthritis, pain, primary dysmenorrhea, crohn's disease and ulcerative colitis..
Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonists
Bayer Pharma Aktiengesellschaft
February 25, 2016 - N°20160052936

Spiroindoline derivatives, processes for their preparation and pharmaceutical compositions thereof, their use for the treatment of diseases, and their use for the manufacture of medicaments for the treatment of diseases, especially sex-hormone-related diseases in both men and women, in particularly those selected from the group of endometriosis, uterine leiomyoma (fibroids), polycystic ovarian disease, menorrhagia, dysmenorrhea, hirsutism, precocious puberty, gonadal steroid-dependent ...
Heterocyclic derivative and pharmaceutical drug
February 18, 2016 - N°20160046612

Wherein r1 and r2 are the same or different aromatic rings, etc., and ring a is a heterocyclic ring. The compound of the invention or a pharmaceutically acceptable salt thereof has potent mpges-1 inhibiting activity and is useful as an agent for the treatment or prevention of a disease, such as rheumatoid arthritis, osteoarthritis, temporomandibular joint disorders, low back pain, ...
Dysmenorrhea Patent Pack
Download + patent application PDFs
Dysmenorrhea Patent Applications
Download + Dysmenorrhea-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dysmenorrhea-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Loading